Argos Therapeutics' Grant - II Round

Argos Therapeutics raised a round of funding on February 12, 2009. Investors include Qualifying Therapeutic Discovery Project.

Argos Therapeutics, formerly Merix Bioscience, s a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infe…

Articles about Argos Therapeutics' Grant - II Round: